Clinical Trial

CMR Versus CT in Coronary Artery Disease

Study acronym: CONCORD
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 1, 2025 (before its estimated November 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
CONCORD is a prospective observational study evaluating the diagnostic accuracy of cardiovascular magnetic resonance (CMR) and computed tomography with fractional flow reserve (CT-FFR) in patients with suspected coronary artery disease, using invasive fractional flow reserve (FFR) as the reference standard.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-02-18; most recent amendment 2025-06-26.
Trial Details
NCT Number NCT04761991
Lead Sponsor University of Leicester
Collaborators: HeartFlow, Inc., National Heart, Lung, and Blood Institute (NHLBI), University of Oxford, University of Glasgow
Conditions Coronary Artery Disease
Enrollment 300 participants
Start Date 2020-11-05
Primary Completion 2025-11-30 (estimated)
Study Completion 2025-11-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-01